Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 51 | 2024 | 13594 | 2.690 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 29 | 2024 | 5434 | 2.480 |
Why?
|
Drug Resistance, Neoplasm | 31 | 2024 | 5342 | 2.420 |
Why?
|
Protein Kinase Inhibitors | 29 | 2024 | 5707 | 1.890 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 11 | 2024 | 1769 | 1.350 |
Why?
|
Cytidine Deaminase | 2 | 2024 | 249 | 0.950 |
Why?
|
Receptors, Prostaglandin | 4 | 2005 | 53 | 0.950 |
Why?
|
Acrylamides | 7 | 2023 | 261 | 0.930 |
Why?
|
Aniline Compounds | 12 | 2023 | 1095 | 0.900 |
Why?
|
Lactams | 7 | 2024 | 159 | 0.870 |
Why?
|
Neoplasm, Residual | 3 | 2024 | 1019 | 0.780 |
Why?
|
Antineoplastic Agents | 16 | 2024 | 13698 | 0.760 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2021 | 567 | 0.720 |
Why?
|
Molecular Targeted Therapy | 12 | 2024 | 2830 | 0.700 |
Why?
|
Aminopyridines | 7 | 2024 | 580 | 0.700 |
Why?
|
Small Cell Lung Carcinoma | 7 | 2024 | 454 | 0.690 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2023 | 1408 | 0.670 |
Why?
|
Mutation | 37 | 2024 | 30266 | 0.650 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2017 | 252 | 0.610 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 260 | 0.600 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2018 | 637 | 0.590 |
Why?
|
Lactams, Macrocyclic | 6 | 2024 | 319 | 0.590 |
Why?
|
Proto-Oncogene Proteins | 8 | 2023 | 4528 | 0.560 |
Why?
|
Neoplasms | 15 | 2024 | 22389 | 0.560 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 755 | 0.560 |
Why?
|
Cell Line, Tumor | 32 | 2024 | 17173 | 0.550 |
Why?
|
Gene Amplification | 2 | 2020 | 1099 | 0.510 |
Why?
|
Apoptosis | 13 | 2021 | 9527 | 0.500 |
Why?
|
Mice, Nude | 9 | 2020 | 3631 | 0.490 |
Why?
|
Receptors, Immunologic | 4 | 2005 | 1418 | 0.480 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2017 | 362 | 0.480 |
Why?
|
Prostaglandin D2 | 2 | 2004 | 108 | 0.440 |
Why?
|
Pyrazoles | 7 | 2024 | 2029 | 0.440 |
Why?
|
Xenograft Model Antitumor Assays | 11 | 2024 | 3621 | 0.440 |
Why?
|
Quinazolines | 2 | 2019 | 1373 | 0.430 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2574 | 0.420 |
Why?
|
MAP Kinase Signaling System | 3 | 2024 | 1495 | 0.400 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2024 | 8664 | 0.340 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2021 | 11886 | 0.340 |
Why?
|
ras Proteins | 2 | 2014 | 1058 | 0.330 |
Why?
|
Genomic Instability | 2 | 2024 | 715 | 0.330 |
Why?
|
Sulfonamides | 8 | 2022 | 1981 | 0.320 |
Why?
|
Animals | 47 | 2024 | 169335 | 0.310 |
Why?
|
Prostaglandins | 4 | 2005 | 398 | 0.300 |
Why?
|
Software | 1 | 2022 | 4479 | 0.300 |
Why?
|
Mice | 34 | 2024 | 82072 | 0.290 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2017 | 1151 | 0.280 |
Why?
|
Humans | 89 | 2024 | 768970 | 0.270 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2960 | 0.270 |
Why?
|
Oncogene Proteins, Fusion | 5 | 2021 | 1616 | 0.250 |
Why?
|
DNA Replication | 2 | 2024 | 1428 | 0.250 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4064 | 0.240 |
Why?
|
Ecdysterone | 1 | 2004 | 13 | 0.240 |
Why?
|
Pyrimidines | 4 | 2023 | 3048 | 0.240 |
Why?
|
Exons | 2 | 2021 | 2395 | 0.230 |
Why?
|
Uracil-DNA Glycosidase | 1 | 2024 | 35 | 0.230 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6131 | 0.220 |
Why?
|
RNA, Small Interfering | 5 | 2019 | 3433 | 0.220 |
Why?
|
Indoles | 3 | 2023 | 1836 | 0.220 |
Why?
|
bcl-X Protein | 3 | 2014 | 412 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2024 | 9442 | 0.210 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2023 | 379 | 0.210 |
Why?
|
Exodeoxyribonucleases | 1 | 2024 | 191 | 0.210 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2023 | 2433 | 0.210 |
Why?
|
Adenylosuccinate Lyase | 1 | 2022 | 4 | 0.210 |
Why?
|
Uracil | 1 | 2024 | 210 | 0.210 |
Why?
|
RNA, Messenger | 3 | 2022 | 12806 | 0.200 |
Why?
|
Signal Transduction | 15 | 2024 | 23653 | 0.200 |
Why?
|
Cell Cycle | 3 | 2021 | 2937 | 0.200 |
Why?
|
Cell Survival | 7 | 2021 | 5793 | 0.190 |
Why?
|
Epigenomics | 2 | 2024 | 961 | 0.190 |
Why?
|
Cysteine | 2 | 2024 | 897 | 0.190 |
Why?
|
Cell Lineage | 2 | 2021 | 2576 | 0.190 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2021 | 59 | 0.190 |
Why?
|
Acetonitriles | 1 | 2021 | 55 | 0.180 |
Why?
|
Cell Proliferation | 7 | 2021 | 10486 | 0.180 |
Why?
|
Hepatocyte Growth Factor | 1 | 2021 | 269 | 0.170 |
Why?
|
Colorectal Neoplasms | 2 | 2017 | 6982 | 0.170 |
Why?
|
Mutagenesis | 1 | 2024 | 1229 | 0.170 |
Why?
|
DNA, Complementary | 2 | 2022 | 1990 | 0.170 |
Why?
|
Xenopus Proteins | 2 | 2000 | 435 | 0.170 |
Why?
|
Quinazolinones | 1 | 2021 | 219 | 0.170 |
Why?
|
Alginates | 1 | 2021 | 250 | 0.160 |
Why?
|
Mice, SCID | 3 | 2019 | 2631 | 0.160 |
Why?
|
Benzamides | 3 | 2021 | 1387 | 0.160 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2023 | 2063 | 0.160 |
Why?
|
Multiprotein Complexes | 3 | 2015 | 1111 | 0.160 |
Why?
|
Diphenylamine | 1 | 2018 | 49 | 0.160 |
Why?
|
Lipoylation | 1 | 2019 | 87 | 0.160 |
Why?
|
Receptor, trkB | 1 | 2019 | 124 | 0.160 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2023 | 608 | 0.150 |
Why?
|
Radiation Tolerance | 1 | 2021 | 478 | 0.150 |
Why?
|
Transforming Growth Factor beta | 3 | 2021 | 2004 | 0.150 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2019 | 2059 | 0.150 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2276 | 0.150 |
Why?
|
Trans-Activators | 4 | 2001 | 2858 | 0.140 |
Why?
|
Acyltransferases | 1 | 2019 | 306 | 0.140 |
Why?
|
DNA Repair | 2 | 2024 | 2054 | 0.140 |
Why?
|
Zinc Fingers | 1 | 2000 | 577 | 0.140 |
Why?
|
Spiro Compounds | 1 | 2017 | 69 | 0.140 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2018 | 224 | 0.140 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2884 | 0.140 |
Why?
|
Amino Acid Sequence | 7 | 2022 | 13427 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2018 | 228 | 0.140 |
Why?
|
Radioligand Assay | 3 | 2012 | 366 | 0.140 |
Why?
|
Drug Synergism | 2 | 2018 | 1762 | 0.130 |
Why?
|
HCT116 Cells | 1 | 2017 | 405 | 0.130 |
Why?
|
Indomethacin | 3 | 2005 | 323 | 0.130 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2020 | 827 | 0.130 |
Why?
|
Dinoprostone | 2 | 2012 | 597 | 0.130 |
Why?
|
Phosphoproteins | 1 | 2024 | 2452 | 0.120 |
Why?
|
Cytomegalovirus | 1 | 2020 | 753 | 0.120 |
Why?
|
Base Sequence | 4 | 2022 | 12430 | 0.120 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2000 | 847 | 0.120 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 874 | 0.120 |
Why?
|
Niacinamide | 1 | 2017 | 418 | 0.120 |
Why?
|
Fatty Acids | 2 | 2021 | 1812 | 0.120 |
Why?
|
Cell Nucleus | 3 | 2020 | 2885 | 0.120 |
Why?
|
DNA Helicases | 1 | 2020 | 854 | 0.120 |
Why?
|
Receptors, Prostaglandin E | 2 | 2004 | 56 | 0.120 |
Why?
|
Ligands | 4 | 2024 | 3283 | 0.110 |
Why?
|
Models, Biological | 5 | 2021 | 9499 | 0.110 |
Why?
|
Quinolines | 1 | 2019 | 772 | 0.110 |
Why?
|
Morpholines | 2 | 2015 | 584 | 0.110 |
Why?
|
Alleles | 3 | 2021 | 6901 | 0.110 |
Why?
|
Tritium | 2 | 2004 | 707 | 0.110 |
Why?
|
Piperazines | 2 | 2021 | 2553 | 0.110 |
Why?
|
Genomics | 2 | 2020 | 5928 | 0.100 |
Why?
|
Receptors, Prostaglandin E, EP3 Subtype | 1 | 2012 | 23 | 0.100 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2012 | 87 | 0.100 |
Why?
|
Transcription Factors | 4 | 2020 | 12174 | 0.100 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1608 | 0.100 |
Why?
|
Lipoprotein Lipase | 1 | 1993 | 133 | 0.100 |
Why?
|
Gene Rearrangement | 1 | 2018 | 1148 | 0.100 |
Why?
|
Gene Deletion | 1 | 2020 | 2674 | 0.100 |
Why?
|
Cyclic AMP | 3 | 2005 | 1469 | 0.100 |
Why?
|
Tumor Burden | 1 | 2018 | 1913 | 0.100 |
Why?
|
Tumor Microenvironment | 3 | 2021 | 3952 | 0.100 |
Why?
|
Immunoconjugates | 1 | 2020 | 976 | 0.100 |
Why?
|
Disease Models, Animal | 6 | 2022 | 18354 | 0.100 |
Why?
|
Antibodies | 1 | 2020 | 2422 | 0.100 |
Why?
|
Adenocarcinoma | 3 | 2016 | 6401 | 0.100 |
Why?
|
DNA-Binding Proteins | 5 | 2001 | 9618 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3671 | 0.090 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1395 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4592 | 0.090 |
Why?
|
Inflammation | 3 | 2019 | 10868 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1483 | 0.080 |
Why?
|
Pyridines | 1 | 2021 | 2895 | 0.080 |
Why?
|
Macrophages | 1 | 2024 | 5801 | 0.080 |
Why?
|
Reactive Oxygen Species | 3 | 2022 | 2149 | 0.080 |
Why?
|
RNA Interference | 1 | 2017 | 2835 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4651 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1629 | 0.080 |
Why?
|
Membrane Glycoproteins | 1 | 2019 | 3713 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2542 | 0.080 |
Why?
|
Blotting, Western | 1 | 2016 | 5033 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9549 | 0.080 |
Why?
|
Cell Movement | 3 | 2005 | 5216 | 0.070 |
Why?
|
Nuclear Proteins | 2 | 2020 | 5804 | 0.070 |
Why?
|
Neuroblastoma | 1 | 2016 | 1266 | 0.070 |
Why?
|
DNA Damage | 3 | 2024 | 2472 | 0.070 |
Why?
|
Benzimidazoles | 1 | 2012 | 864 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2005 | 1683 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20245 | 0.070 |
Why?
|
Membrane Proteins | 4 | 2015 | 7885 | 0.070 |
Why?
|
Oxidation-Reduction | 2 | 2024 | 2226 | 0.070 |
Why?
|
Cell Line | 6 | 2005 | 15604 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2020 | 14484 | 0.070 |
Why?
|
Prognosis | 4 | 2020 | 30046 | 0.070 |
Why?
|
Female | 22 | 2024 | 397515 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3811 | 0.070 |
Why?
|
Mice, Inbred NOD | 2 | 2022 | 1839 | 0.060 |
Why?
|
Heparin | 1 | 1993 | 1636 | 0.060 |
Why?
|
Amino Acid Substitution | 2 | 2021 | 1742 | 0.060 |
Why?
|
Rhodobacter | 1 | 2005 | 1 | 0.060 |
Why?
|
Protein Binding | 4 | 2005 | 9344 | 0.060 |
Why?
|
Photosynthetic Reaction Center Complex Proteins | 1 | 2005 | 11 | 0.060 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2005 | 89 | 0.060 |
Why?
|
Selenomethionine | 1 | 2005 | 18 | 0.060 |
Why?
|
Dinoprost | 1 | 2005 | 139 | 0.060 |
Why?
|
Cell Division | 2 | 2004 | 4478 | 0.060 |
Why?
|
Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2004 | 10 | 0.060 |
Why?
|
Kidney Tubules, Collecting | 1 | 2005 | 163 | 0.060 |
Why?
|
Receptors, Epoprostenol | 1 | 2004 | 12 | 0.060 |
Why?
|
Chemotactic Factors | 1 | 2005 | 197 | 0.060 |
Why?
|
Oncogene Proteins | 2 | 2021 | 718 | 0.060 |
Why?
|
Smad4 Protein | 3 | 2001 | 193 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2022 | 5196 | 0.060 |
Why?
|
Lac Operon | 2 | 2005 | 237 | 0.060 |
Why?
|
Models, Molecular | 3 | 2021 | 5404 | 0.060 |
Why?
|
SOXE Transcription Factors | 1 | 2024 | 73 | 0.060 |
Why?
|
Biopsy | 3 | 2021 | 6805 | 0.060 |
Why?
|
Binding, Competitive | 1 | 2005 | 1142 | 0.060 |
Why?
|
Phenylalanine | 1 | 2005 | 368 | 0.060 |
Why?
|
Eicosanoids | 1 | 2005 | 284 | 0.050 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2018 | 719 | 0.050 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2023 | 42 | 0.050 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2018 | 615 | 0.050 |
Why?
|
Xenopus | 3 | 2000 | 711 | 0.050 |
Why?
|
Alanine | 1 | 2005 | 614 | 0.050 |
Why?
|
Cloning, Molecular | 4 | 2005 | 4168 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4756 | 0.050 |
Why?
|
Chemotaxis | 1 | 2005 | 600 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2020 | 65480 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2041 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2005 | 2749 | 0.050 |
Why?
|
Smad Proteins | 2 | 2000 | 157 | 0.050 |
Why?
|
Molecular Sequence Data | 7 | 2005 | 17629 | 0.050 |
Why?
|
Porosity | 1 | 2022 | 352 | 0.050 |
Why?
|
Transfection | 3 | 2005 | 5763 | 0.050 |
Why?
|
Immunoglobulin Light Chains | 1 | 2022 | 289 | 0.050 |
Why?
|
Calcium Chloride | 1 | 2021 | 79 | 0.050 |
Why?
|
Tyrosine | 1 | 2005 | 1427 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2023 | 3139 | 0.050 |
Why?
|
Melanoma | 2 | 2024 | 5709 | 0.040 |
Why?
|
Mitochondria | 1 | 2014 | 3682 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2016 | 1105 | 0.040 |
Why?
|
Vero Cells | 1 | 2021 | 486 | 0.040 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2021 | 318 | 0.040 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2021 | 134 | 0.040 |
Why?
|
Radiobiology | 1 | 2020 | 90 | 0.040 |
Why?
|
Proteomics | 2 | 2022 | 3914 | 0.040 |
Why?
|
Surgical Mesh | 1 | 2022 | 316 | 0.040 |
Why?
|
Smad2 Protein | 1 | 2000 | 144 | 0.040 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2001 | 306 | 0.040 |
Why?
|
Smad3 Protein | 1 | 2000 | 166 | 0.040 |
Why?
|
Kidney | 2 | 2005 | 7058 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2021 | 4926 | 0.040 |
Why?
|
Glutamic Acid | 1 | 2005 | 1191 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14201 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2021 | 349 | 0.040 |
Why?
|
Freezing | 1 | 2020 | 311 | 0.040 |
Why?
|
Aged | 10 | 2021 | 171786 | 0.040 |
Why?
|
Water | 1 | 2005 | 1421 | 0.040 |
Why?
|
Triazines | 1 | 2021 | 311 | 0.040 |
Why?
|
Mucin-1 | 1 | 2023 | 539 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10765 | 0.040 |
Why?
|
Purines | 1 | 2022 | 615 | 0.040 |
Why?
|
Models, Theoretical | 2 | 2021 | 3580 | 0.040 |
Why?
|
Yeasts | 1 | 2000 | 279 | 0.040 |
Why?
|
NAD | 1 | 2023 | 618 | 0.040 |
Why?
|
src Homology Domains | 1 | 2019 | 361 | 0.040 |
Why?
|
Cell Growth Processes | 1 | 2019 | 381 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2018 | 50 | 0.040 |
Why?
|
Lentivirus | 1 | 2021 | 518 | 0.040 |
Why?
|
Phylogeny | 2 | 2004 | 2843 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3775 | 0.040 |
Why?
|
Phagocytosis | 1 | 2024 | 1530 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3813 | 0.040 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2019 | 246 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7609 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 874 | 0.040 |
Why?
|
COS Cells | 1 | 2000 | 1135 | 0.040 |
Why?
|
Clone Cells | 1 | 2021 | 1670 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2005 | 1248 | 0.040 |
Why?
|
Computational Biology | 2 | 2020 | 3562 | 0.040 |
Why?
|
DNA | 2 | 2022 | 7214 | 0.040 |
Why?
|
Kinetics | 1 | 2005 | 6332 | 0.040 |
Why?
|
Indazoles | 1 | 2019 | 306 | 0.040 |
Why?
|
Virus Internalization | 1 | 2021 | 503 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 393 | 0.040 |
Why?
|
Amyloid | 1 | 2022 | 854 | 0.040 |
Why?
|
Growth Substances | 2 | 1996 | 760 | 0.040 |
Why?
|
Protein Conformation | 3 | 2012 | 3956 | 0.040 |
Why?
|
Phosphorylation | 3 | 2019 | 8317 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2004 | 6512 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2019 | 386 | 0.030 |
Why?
|
Phthalazines | 1 | 2019 | 397 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2021 | 1439 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 19023 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2019 | 1162 | 0.030 |
Why?
|
Male | 13 | 2024 | 365203 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2005 | 1173 | 0.030 |
Why?
|
Middle Aged | 9 | 2021 | 223737 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2000 | 1524 | 0.030 |
Why?
|
Hepatitis C | 2 | 1997 | 1595 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 2018 | 0.030 |
Why?
|
Protons | 1 | 2021 | 1113 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2492 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3057 | 0.030 |
Why?
|
Repressor Proteins | 2 | 1996 | 2986 | 0.030 |
Why?
|
Cell Membrane | 1 | 2005 | 3659 | 0.030 |
Why?
|
Sulfones | 1 | 2018 | 448 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1735 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 724 | 0.030 |
Why?
|
Dexamethasone | 1 | 2022 | 1965 | 0.030 |
Why?
|
Oocytes | 1 | 2000 | 1172 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2023 | 2460 | 0.030 |
Why?
|
Imidazoles | 1 | 2021 | 1169 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2005 | 5906 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 551 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2024 | 2848 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 968 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 466 | 0.030 |
Why?
|
Pyridones | 1 | 2019 | 819 | 0.030 |
Why?
|
Oncogenes | 1 | 2020 | 1236 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2000 | 1143 | 0.030 |
Why?
|
Ribosomal Protein S6 | 1 | 2013 | 70 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 59739 | 0.030 |
Why?
|
Encephalitis | 1 | 2017 | 441 | 0.030 |
Why?
|
Antioxidants | 1 | 2021 | 1673 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2020 | 1363 | 0.030 |
Why?
|
Proteins | 2 | 2000 | 6011 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13674 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.030 |
Why?
|
Rabbits | 2 | 2012 | 4774 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2020 | 2204 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1625 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1328 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 1997 | 1064 | 0.030 |
Why?
|
Adult | 8 | 2021 | 223851 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4148 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22379 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2024 | 3080 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2004 | 2543 | 0.020 |
Why?
|
Gene Silencing | 1 | 2018 | 1505 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 1993 | 525 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 737 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2000 | 3612 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3163 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2019 | 2395 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3836 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1755 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2000 | 2431 | 0.020 |
Why?
|
DNA Methylation | 1 | 2024 | 4432 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6547 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1520 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2015 | 1748 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3232 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2015 | 936 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2408 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 5505 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3450 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2016 | 2916 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2537 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4124 | 0.020 |
Why?
|
Hepacivirus | 1 | 1995 | 1344 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6291 | 0.020 |
Why?
|
Genotype | 3 | 2016 | 13048 | 0.020 |
Why?
|
Point Mutation | 1 | 2012 | 1596 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2000 | 4413 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41808 | 0.020 |
Why?
|
Brain | 2 | 2024 | 27453 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8513 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5110 | 0.020 |
Why?
|
Smad1 Protein | 2 | 1996 | 81 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8559 | 0.020 |
Why?
|
Embryonic Induction | 2 | 1996 | 152 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5801 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2942 | 0.020 |
Why?
|
Prostaglandins F, Synthetic | 1 | 2005 | 32 | 0.020 |
Why?
|
Pertussis Toxin | 1 | 2005 | 176 | 0.020 |
Why?
|
Synchrotrons | 1 | 2005 | 40 | 0.020 |
Why?
|
Ribonucleases | 1 | 2005 | 266 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18435 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6214 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8055 | 0.010 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2004 | 44 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 2005 | 417 | 0.010 |
Why?
|
Cyclooxygenase 1 | 1 | 2004 | 98 | 0.010 |
Why?
|
Crystallization | 1 | 2005 | 520 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 1996 | 325 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2005 | 265 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20776 | 0.010 |
Why?
|
Rats | 1 | 2000 | 23786 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15951 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 318 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4290 | 0.010 |
Why?
|
Time Factors | 2 | 2020 | 40261 | 0.010 |
Why?
|
Spectrum Analysis | 1 | 2005 | 449 | 0.010 |
Why?
|
Lung | 1 | 2021 | 10099 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11116 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 60131 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 2004 | 429 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12873 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2004 | 361 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2004 | 319 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2004 | 597 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11262 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1904 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2005 | 2298 | 0.010 |
Why?
|
Ovary | 1 | 2005 | 965 | 0.010 |
Why?
|
Perfusion | 1 | 2005 | 1402 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9264 | 0.010 |
Why?
|
China | 2 | 1997 | 2395 | 0.010 |
Why?
|
Isoenzymes | 1 | 2004 | 1687 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11932 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36556 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3588 | 0.010 |
Why?
|
Hepatitis C Antibodies | 1 | 1997 | 151 | 0.010 |
Why?
|
Inhibins | 1 | 1996 | 210 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9213 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2005 | 3412 | 0.010 |
Why?
|
Activins | 1 | 1996 | 211 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6232 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39394 | 0.010 |
Why?
|
Child | 2 | 2020 | 80960 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1057 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 1996 | 564 | 0.010 |
Why?
|
Mesoderm | 1 | 1996 | 679 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 1995 | 405 | 0.010 |
Why?
|
Embryo, Nonmammalian | 1 | 1996 | 910 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 1997 | 1952 | 0.010 |
Why?
|
Calcium | 1 | 2005 | 5792 | 0.010 |
Why?
|
DNA Primers | 1 | 1995 | 2827 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 54962 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 81903 | 0.000 |
Why?
|
Liver Diseases | 1 | 1997 | 1305 | 0.000 |
Why?
|
Drosophila | 1 | 1996 | 1513 | 0.000 |
Why?
|
DNA, Viral | 1 | 1995 | 2205 | 0.000 |
Why?
|
Drosophila Proteins | 1 | 1996 | 1712 | 0.000 |
Why?
|
Halothane | 1 | 1966 | 200 | 0.000 |
Why?
|
RNA, Viral | 1 | 1995 | 2871 | 0.000 |
Why?
|
Anesthesia, Inhalation | 1 | 1966 | 220 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6086 | 0.000 |
Why?
|
Escherichia coli | 1 | 1997 | 4213 | 0.000 |
Why?
|
Propranolol | 1 | 1966 | 493 | 0.000 |
Why?
|
Prevalence | 1 | 1997 | 15879 | 0.000 |
Why?
|
Cardiovascular System | 1 | 1966 | 841 | 0.000 |
Why?
|
Dogs | 1 | 1966 | 3845 | 0.000 |
Why?
|
Hemodynamics | 1 | 1966 | 4199 | 0.000 |
Why?
|